one more thing...I consulted w/Dr. Larry Norton @Memorial Sloan Kettering-he's the head of breast oncology & a large contributor to the development of Herceptin and very, very research oriented.
When I asked about the use of thalidomide, off-label, he instantly said "Absolutely not.Certainly not unless in clinical trial." It seems to be an uphill battle! |
All times are GMT -7. The time now is 01:34 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021